Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$61.1K
7.87K shares
What this filing means
SWARTZ ROBIN plans to sell 7.87K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $61.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2024ACC: 0001959173-24-002752
Officer· Chief Operating Officer
Since Feb 2022
7.87K
Shares to sell
$61.1K
Approx. market value
1.36K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
4/1/2024
1.36KTotal acquired1.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2024 | Restricted Stock Vesting Compensation | 1.36K | — |
| Total | 1.36K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.97K
Market value
$29.6K
2/21/2024
—Completed
Units to sell
2.54K
Market value
$18.2K
1/17/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.36K
Market value
$13.4K
4/2/2024
Total
Units
7.87K
Value
$61.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/21/2024 | 3.97K | $29.6K | — | Completed |
1/17/2024 | 2.54K | $18.2K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2024 | 1.36K | $13.4K | NASDAQ | Planned |
| Total | 7.87K | $61.1K | ||